IDO1 and neoplasm: This suggests that tumor cell associated IDO1 also has a tumor-promoting effect via a non-immune related function and therefore, apart from targeting IDO1 in the DCs, targeting tumor cell IDO1 might prove as a beneficial therapeutic strategy as well.